Mount Yale Investment Advisors, LLC - LIGAND PHARMACEUTICALS INC ownership

LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 389 filers reported holding LIGAND PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.46 and the average weighting 0.3%.

Quarter-by-quarter ownership
Mount Yale Investment Advisors, LLC ownership history of LIGAND PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$136,000
-25.3%
837
-4.8%
0.02%
-29.4%
Q2 2018$182,000
+54.2%
879
+23.1%
0.03%
+36.0%
Q1 2018$118,0007140.02%
Other shareholders
LIGAND PHARMACEUTICALS INC shareholders Q3 2018
NameSharesValueWeighting ↓
KNOTT DAVID M 1,199,766$130,078,630,00035.65%
CARDINAL CAPITAL MANAGEMENT LLC /CT 852,053$92,380,0005.34%
OBERWEIS ASSET MANAGEMENT INC/ 101,127$10,964,0003.08%
Timpani Capital Management LLC 68,160$7,390,0003.00%
ASHFORD CAPITAL MANAGEMENT INC 103,420$11,213,0002.64%
First Light Asset Management, LLC 56,818$6,160,0002.58%
Conestoga Capital Advisors, LLC 286,162$31,026,0002.51%
OAK RIDGE INVESTMENTS LLC 955,599$103,606,0002.48%
RK Capital 127,983$13,876,0002.42%
Nichols Asset Management LLC 93,170$10,101,0002.20%
View complete list of LIGAND PHARMACEUTICALS INC shareholders